Skip To Main Content
Julia R. Barrett on Muck Rack

Julia R. Barrett

As seen in: Environmental Health Perspectives, Nature, Wiley Online Library, Science Magazine, Cell Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Julia R.

Contact Julia R., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Organ injury in systemic autoimmunity is mediated by stem-like CD8 + T cells arising from tissue-draining lymph nodes

|
By Jafar Al Souz, Yulong Wei, Can Cui, Rihao Qu, Jin-Young Choi, Fang Wang, Steven J. Moioffer, Julia R. Barrett, Irene Chernova, Emily R. Siniscalco, Gilbert Moeckel, Nikhil Joshi, Ping-Min Chen, Arnon Arazi, Manvitha Nadella
| Cell Press Verified
Open in Who Shared Issue with article?

Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques - Nature Communications

|
By Laura Solforosi, David Hope, Tetyana Murdza, Julia R. Barrett, Cindy Wu, Nicole P. Hachmann, Dan Barouch, Hanneke Schuitemaker, Roland Zahn
| Nature Verified
Abstract Omicron spike (S) encoding vaccines as boosters, are a potential strategy to improve COVID-19 vaccine efficacy against Omicron. Here, macaques (mostly females) previously immunized with Ad26.COV2.S, are boosted with Ad26.COV2.S, Ad26.COV2.S.529 (encoding Omicron BA.1 S) or a 1:1 combination of both vaccines. All booster vaccinations elicit a rapid antibody titers increase against WA1/2020 and Omicron S.
Open in Who Shared Issue with article?

Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques - npj Vaccines

|
By Jingyou Yu, David Hope, Daniel Sellers, Julia R. Barrett, Mark Lewis, Hanne Leth Andersen, Nichole P. Hachmann
| Nature Verified
Abstract Despite the availability of several effective SARS-CoV-2 vaccines, additional vaccines will be required for optimal global vaccination. In this study, we investigate the immunogenicity and protective efficacy of the GBP510 protein subunit vaccine adjuvanted with AS03, which has recently been authorized for marketing in South Korea under the trade name SKYCovioneTM.
Open in Who Shared Issue with article?
See all 22 licensed articles (27 Total)